I am astonished at the subdued response to the news of BARDA...

I am astonished at the subdued response to the news of BARDA funding for phase 3 trials for LANI worldwide.

My concerns crystallised this morning by the takeover of CST for A$341m.

Surely BTA is worth at least as much as CST and arguably more. But we are capitalised a "mere" A$259m.

Without going into all the detail - it's all here on HC, we are in grave danger of premature death through takeover. There are many Life Sciences companies for whom we would be a perfect fit and company maker.

I hope management feel the same.